957 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: ARN-509;   Drug: Placebo
22 Recruiting Pilot Study of SBRT and CDX-1127 in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: CDX1127;   Radiation: SBRT
23 Recruiting Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: NSAA;   Drug: LHRHA or Surgical Castration
24 Recruiting A Registry of Participants With Prostate Cancer in Asia
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
25 Recruiting Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Neoplasms, Prostate
Interventions: Biological: PROSTVAC-V/TRICOM;   Biological: PROSTVAC-F/TRICOM
26 Not yet recruiting Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic body RT with MR-guided boost
27 Recruiting Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Conditions: Cancer of the Prostate;   Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Metformin
28 Recruiting Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Procedure: Prostatectomy/Surgery;   Other: Radiotherapy with adjuvant androgen deprivation therapy
29 Recruiting Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer
Conditions: Fasting;   Prostatic Neoplasms
Interventions: Other: Fasting;   Other: Control
30 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
31 Recruiting An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ56021927;   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Placebo
32 Recruiting Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
Conditions: Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
33 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Interventions: Biological: androgen ablation (AA);   Biological: DC1 vaccine
34 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:
35 Recruiting Gallium-68 Citrate PET Used in Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Procedure: Gallium-68 citrate PET
36 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
37 Recruiting Fusion Guided Focal Laser Ablation of Prostate Cancer
Conditions: Prostate Cancer;   Prostate Neoplasms
Intervention: Device: 1.2.Laser Ablation Device
38 Recruiting Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: phenelzine sulfate;   Other: laboratory biomarker analysis;   Other: questionnaire administration
39 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
40 Recruiting Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Doxorubicin;   Drug: Ketoconazole;   Drug: Docetaxel;   Drug: Estramustine;   Drug: Degarelix

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years